[Left ventricular myocardial geometry in arterial hypertension in patients with stenosing cerebral atherosclerosis]

Insights

Arterial hypertension and atherosclerosis impact blood flow and heart structure. Moderate carotid artery narrowing shows hyperkinetic flow, while severe narrowing indicates hypodynamic flow and more left ventricular remodeling.

Area of Science:

  • Cardiology
  • Neurology
  • Vascular Medicine

Background:

  • Arterial hypertension (AH) and cerebral atherosclerosis are significant cardiovascular risk factors.
  • Circulatory and hemodynamic disturbances are common in patients with AH and cerebral atherosclerosis.
  • Myocardial remodeling is a known consequence of sustained hemodynamic stress.

Purpose of the Study:

  • To clarify the relationship between common carotid artery (CCA) circulatory issues and hemodynamic/myocardial remodeling in AH patients with cerebral atherosclerosis.
  • To investigate how the degree of CCA stenosis influences hemodynamic patterns and left ventricular (LV) structure.
  • To understand the progression of atherosclerotic lesions and their impact on cardiovascular remodeling.

Main Methods:

  • Carotid arterial Doppler ultrasonography was used to assess CCA hemodynamics.
  • Echocardiography (echoCG) evaluated structural myocardial remodeling.
  • Central hemodynamic variables were measured in 83 patients with AH and cerebral atherosclerosis.

Main Results:

  • Patients with moderate CCA stenosis and AH more frequently exhibited a hyperkinetic hemodynamic type.
  • Patients with severe CCA stenosis and AH were more commonly associated with a hypodynamic hemodynamic type.
  • Left ventricular myocardial remodeling, particularly asymmetric hypertrophy, was more prevalent in patients with severe CCA stenosis.

Conclusions:

  • The severity of CCA stenosis correlates with specific hemodynamic patterns (hyperkinetic vs. hypodynamic) in patients with AH and cerebral atherosclerosis.
  • Severe CCA stenosis is linked to a higher incidence of LV myocardial remodeling.
  • Dissociation between central and regional hemodynamics, driven by atherosclerotic progression, contributes to myocardial remodeling.

Related Concept Videos

Coordination Number and Geometry02:57

Coordination Number and Geometry

For transition metal complexes, the coordination number determines the geometry around the central metal ion. Table 1 compares coordination numbers to molecular geometry. The most common structures of the complexes in coordination compounds are octahedral, tetrahedral, and square planar.
19.0K
Predicting Molecular Geometry02:27

Predicting Molecular Geometry

VSEPR Theory for Determination of Electron Pair Geometries
45.6K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
584
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
450
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
478
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
601